# The Effects of Alendronate After Cure of Primary Hyperparathyroidism

> **NCT00359385** · PHASE4 · WITHDRAWN · sponsor: **Columbia University**

## Conditions studied

- Hyperparathyroidism

## Interventions

- **DRUG:** Alendronate 70mg weekly

## Key facts

- **NCT ID:** NCT00359385
- **Lead sponsor:** Columbia University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2006-07
- **Primary completion:** 2009-09
- **Final completion:** 2009-09
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** incomplete enrollment
- **Last updated:** 2011-11-16

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00359385

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00359385, "The Effects of Alendronate After Cure of Primary Hyperparathyroidism". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT00359385. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*